D
Deborah Grady
Researcher at University of California, San Francisco
Publications - 276
Citations - 44747
Deborah Grady is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Estrogen & Hormone therapy. The author has an hindex of 88, co-authored 269 publications receiving 43348 citations. Previous affiliations of Deborah Grady include Veterans Health Administration & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Variability and Accuracy in Mammographic Interpretation Using the American College of Radiology Breast Imaging Reporting and Data System
Karla Kerlikowske,Deborah Grady,John Barclay,S D Frankel,S H Ominsky,Edward A. Sickles,Virginia L. Ernster +6 more
TL;DR: Considerable variability in interpretation of mammographic examinations exists; this variability and the accuracy of mammography are neither improved nor diminished with use of BI-RADS.
Journal ArticleDOI
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Lori Mosca,Lawrence J. Appel,Emelia J. Benjamin,Kathy Berra,Nisha Chandra-Strobos,Rosalind P. Fabunmi,Deborah Grady,Constance K. Haan,Sharonne N. Hayes,Debra R. Judelson,Nora L. Keenan,Patrick McBride,Suzanne Oparil,Pamela Ouyang,Mehmet C. Oz,Michael E. Mendelsohn,Richard C. Pasternak,Vivian W. Pinn,Rose Marie Robertson,Karin Schenck-Gustafsson,Cathy A. Sila,Sidney C. Smith,George Sopko,Anne L. Taylor,Brian W. Walsh,Nanette K. Wenger,Christine L. Williams +26 more
TL;DR: In the wake of the reports of the Women's Health Initiative and the Heart and Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that combination hormone therapy was associated with adverse CVD effects, there is a heightened need to critically review and document strategies to prevent CVD in women.
Journal ArticleDOI
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor,Lori Mosca,Peter Collins,Mary Jane Geiger,Deborah Grady,Marcel Kornitzer,Michelle A. Mcnabb,Nanette K. Wenger +7 more
TL;DR: The benefits of raloxifene in reducing the risks of invasive breast cancer and vertebral fracture should be weighed against the increased risks of venous thromboembolism and fatal stroke.
Journal ArticleDOI
Hysterectomy and urinary incontinence: a systematic review
TL;DR: When women are counselled about sequelae of hysterectomy, practitioners should discuss the possibility of an increased likelihood of incontinence in later life.